“Adjuvant Therapy With Nivolumab Versus Placebo in Patients With Resected Stage IIB C Melanoma (CheckMate 76K)”. 2023. SKIN The Journal of Cutaneous Medicine 7 (2): s163. https://doi.org/10.25251/skin.7.supp.163.